Background. The ability of Staphylococcus aureus to adhere to platelets and to induce aggregation of platelets is considered to be a critical factor in S. aureus-associated infective endocarditis.
. In recent years, significant progress has been made in the identification of S. aureus surface proteins that are able to mediate adherence to platelets and to promote endocarditis. In particular, S. aureus surface proteins of the MSCRAMM (microbial surface components recognizing adhesive matrix molecules) family [7] have been implicated in this process. Thus, protein A (encoded by spa), which binds IgG and von Willebrand factor [8] , has been identified as a surface protein conferring S. aureus binding to platelets via the platelet membrane protein gC1qR/p33 [9] . Furthermore, the Fg-binding clumping factor A (ClfA) is involved in the development of experimental endocarditis, which seems, at least in part, to be mediated through its direct binding to a novel 118-kDa platelet membrane receptor [10] [11] [12] .
The surface display of portions of bacterial adhesins on hybrid phages, followed by affinity selection, is a useful tool to identify and characterize protein-ligand interactions. We recently found that the C-terminal domain of the S. aureus coagulase and the N-terminal domain of the extracellular Fgbinding protein (Efb) are involved in platelet binding, probably via Fg as a bridging molecule, by use of the phage-display technique [13] . However, ∼50% of the eluted phagemids did not contain an insert with an open-reading frame (ORF) and thus represented nonspecifically bound phagemids. Therefore, to identify and characterize further S. aureus adhesins involved in the S. aureus-platelet interaction, we generated a new phage-display library by use of the improved phagemid vector pG8SAET. This vector allows the identification of ORFs by detection of the artificial E-tag and has proven to be suitable when complex mixtures of ligands, such as eukaryotic cells, are used in the pannings [14, 15] . Analogous to our former study, platelet-binding hybrid phages were affinity-selected via panning against gel-purified, immobilized platelets. By use of this approach, we were able to identify the S. aureus Fn-binding proteins (FnBPs) as mediators of S. aureus adherence to platelets. Furthermore, we found that FnBPA, but not FnBPB, is able to induce aggregation of platelets.
MATERIALS AND METHODS
Bacterial strains, phagemid vector, helper phage, media, and reagents. The clinical isolate S. aureus 4074 [13] was used as the DNA donor strain, and the phagemid pG8SAET [15] served as the vector in the construction of the phage-display library. Escherichia coli TG1 was used to construct the library and to produce the enriched phage stocks [16] . Phage R408 (Promega) was used as a helper phage. Staphylococcus carnosus (pFNBA4) and S. carnosus (pFNBB4), which express fnbA and fnbB from S. aureus 8325-4 [17] , respectively, were used to analyze the platelet-binding potential of FnBPA and FnBPB. Plasmids pFNBA4 and pFNBB4 have been described elsewhere [18] . S. aureus Cowan 1 (ATCC 12598) and S. carnosus TM300 [19] served as positive and negative controls, respectively.
Staphylococcal strains were grown on blood agar plates or on brain-heart infusion (BHI) plates, in BHI broth (Difco) or Bmedium [19] , containing 10 mg/mL chloramphenicol when appropriate. E. coli strains were cultivated in Luria-Bertani (LB) medium (Difco) or on LA plates (LB medium with 1.5% agar; Difco), which contained 50 mg/mL ampicillin when appropriate.
Bovine serum albumin (BSA), a-thrombin (bovine), and Fn from human plasma were purchased from Sigma. The peptide GPRP (Gly-Pro-Arg-Pro) was purchased from Bachem AG. Human Fg was purchased from Enzyme Research Labs. Monoclonal antibody against human CD42a (GP IX) (conjugated with phycoerythrin [PE]) was purchased from Exalpha via NatuTec. Syto 13 for labeling of S. aureus was purchased from Molecular Probes via Mobitec.
DNA manipulations, transformation of E. coli, preparation of phage stocks, and DNA sequencing. DNA manipulations, transformation of E. coli, and preparation of phage stocks were performed according to standard procedures [20] . Preparation of chromosomal and plasmid DNA, polymerase chain reaction (PCR), and DNA sequence analysis were performed as described elsewhere [13] . The following primers were used to amplify the inserts of isolated hybrid phagemids by PCR and for DNA sequencing: CH60 (5 -TGGTGGCGTAACACCTGC-TGC-3 ) and CH61 (5 -GATCCCTAGGCACGCGGTTCC-3 ).
Construction of the phagemid library. The phagemid library was constructed essentially as described elsewhere [13] , except that the vector was linearized with SnaBI.
Preparation of platelets. Blood was obtained from healthy adult volunteers who had not taken any medication affecting platelet function for at least 2 weeks before the study. All experiments were performed with the informed consent of the blood donors. Platelets for panning were purified as described elsewhere [13] . For flow-cytometric analysis, platelet-rich plasma (PRP) was prepared from anticoagulated blood by centrifugation, as described elsewhere [21] , and the platelets were gel-filtered on a Sephadex Cl-2B column [21] . In some experiments, Fn or Fg (25, 50, or 100 mg/mL) was added. To inhibit fibrin polymerization, experiments were performed in the presence of the peptide GPRP (1.25 mmol/L) [21] . The platelets were labeled by incubation for 30 min with a monoclonal antibody against CD42a (GP IX) conjugated with PE, at saturated concentrations.
Panning procedure. Panning against platelets was performed as described elsewhere [13] , except that 3 instead of 2 rounds of panning were performed.
Screening for expression of the E-tag. Expression of the E-tag was detected as described elsewhere [15] , except that nitrocellulose membranes were blocked with 1% BSA in Tris-buffered saline containing 0.05% Tween 20 (TBS-T) for 1 h and washed with TBS-T.
Preparation of bacteria for flow-cytometric platelet-adherence assay and measurement of the formation of S. aureusplatelet associates.
Bacteria grown to exponential phase (OD 600nm of 0.8) or to stationary phase (16 h) in BHI broth were washed in TBS (pH 7.4), briefly sonicated (10 cycles, each of 1 s, 50 W; Branson), and diluted with TBS (containing 2 mmol/L Ca 2+ ) to a concentration of 250,000 bacteria/mL. Microorganisms were labeled with the fluorescent dye Syto 13 (emission similar to fluorescein isothiocyanate [FITC] ), at a concentration of 2 mmol/L, for 10 min, washed in TBS, and again briefly sonicated as described above.
Platelets were activated with a-thrombin at the given concentrations for 4 min, and labeled bacteria were added subsequently. Bacteria and platelets (10:1) were coincubated for 15 min at room temperature, and formation of conjugates was measured immediately thereafter (FACSCalibur flow cytometer; Becton Dickinson). Associates were identified by use of double labeling with Syto 13 (FL-1; "FITC-like" signal) and antiCD42a-PE (FL-2; PE signal) and are given as the rate of bacteria-positive platelets. Shown are the mean values of 3 independent experiments.
Measurement of aggregation of platelets. Aggregation of platelets was assayed essentially as described elsewhere [22] , except that staphylococcal cells were added to PRP adjusted with platelet-poor plasma to a concentration of plate- 6 2 ϫ 10 lets/mL or to gel-filtered platelets (GFPs) adjusted to a concentration of platelets/mL. Platelet function was confirmed 6 2 ϫ 10 in independent experiments by the addition of a-thrombin. No inhibitors were added. Platelets were assayed for 2 min in an aggregometer (P.I.C.A.; Chrono-log) before the addition of the bacteria.
Statistical analysis. The results are expressed as mean ‫ע‬ SD. Statistical significance was determined by use of the unpaired Student's t test. The significance level was defined as . P ! .05
RESULTS

Phage-Display Library
We constructed a phage-display library by random insertion of fragmented chromosomal DNA of strain 4074 into gene VIII of the phagemid vector pG8SAET. The phage-display library consisted of clones and had, after infection with helper 7 1.9 ϫ 10 phage, a titer of cfu/mL. Approximately 93.5% of all 11 1.5 ϫ 10 clones had an insert, with an average size of 305 bp. Thus, according to the criteria of Clarke and Carbon [23] , the library was representative of the S. aureus genome. Therefore, portions of all proteins encoded by the genome should be expressed on the phage surfaces in fusion to the major coat protein VIII (pVIII) of the M13 phage.
Panning of the Library against Platelets
To identify further platelet-binding domains of bacterial receptors, the library was affinity-panned against immobilized GFPs. After the third panning, an ∼20-fold enrichment of platelet affinity-selected phages was observed. Previous results have shown that this enrichment is specific when bacteria possess a receptor for the ligand used in the panning and that there is no enrichment observed when bacteria do not express a specific receptor, as shown in pannings against human serum albumin [13, 24] . To identify potentially correct clones (i.e., phagemid clones carrying an insert containing an ORF that corrects the reading frame so that the artificial E-tag and, thus, gene VIII [encoding pVIII] is expressed), we performed colony blot analysis and further analyzed E-tag-positive clones.
Analysis of Affinity-Selected Clones by Panning against Platelets
Size determination of inserted DNA fragments. Plasmid DNA of 57 E-tag-positive colonies obtained after the third panning against platelets was prepared and used to amplify the inserted DNA fragment by use of PCR. Analysis of the fragments by electrophoresis in 2% agarose gels revealed that all clones were isolated repeatedly and contained 1 of the following DNA fragments: 700, 580, 390, 330, 300, or 290 bp.
Nucleotide sequence analysis of inserted DNA fragments. The nucleotide sequence of the amplified DNA fragments was determined. Sequence analysis of the 330-bp (represented by clone Pf) and 300-bp (clone Pg) fragments revealed that they share identical nucleotide sequences encoding the same protein domain in fusion with pVIII. Comparison of the deduced amino acid sequences of clones Pf (112 aa) and Pg (100 aa) with sequences of known proteins in the Swiss-Prot database (available at: http://www.ebi.ac.uk/swissprot) revealed identity or high similarity with a portion of the central domain of the S. aureus FnBPs ( figure 1A) . Alignment of the clones Pf and Pg with the respective domains of the FnBPs revealed 100% identical amino acids with the D domain of FnBPB from strain MW2 [26] , 98% identical amino acids with the same domain of FnBPA from strain N315 and Mu50 [27] , 98% identical amino acids (Pf) or 99% identical amino acids (Pg) with the homologous D domain of FnBPA from strain 8325-4 [28] , and 97% identical amino acids with the homologous D domain of FnBPB from strain 8325-4 [29] (figure 1B). All other DNA fragments encoded either the N-terminal domain of Efb or the C-terminal portion of the coagulase, confirming our previous results [13] .
Flow-Cytometric Analysis of the Platelet-Binding Capacity of S. aureus FnBPA and FnBPB
To elucidate the role that the FnBPs play in the S. aureusplatelet interaction, we performed a flow-cytometric platelet adherence assay. Because of the redundancy of mechanisms that are involved in the binding of S. aureus to platelets, it is difficult to assess the function of an isolated factor in the S. aureus background. Indeed, we could not find a difference in platelet adherence between the S. aureus wild-type (wt) strains Newman and 8325-4 and their isogenic fnbA/fnbB double-knockout mutant strains (data not shown). Therefore, we heterologously expressed the genes encoding FnBPA and FnBPB (fnbA, encoded by the plasmid pFNBA4, and fnbB, encoded by the plasmid pFNBB4) in the nonpathogenic and non-platelet-binding host strain S. carnosus [17] . The platelet-binding activity of S. carnosus (pFNBA4) and S. carnosus (pFNBB4), compared with that of the S. carnosus wt strain as a negative control and that of S. aureus Cowan 1 as a positive control, was analyzed. Adherence of stationary-phase S. aureus Cowan 1, S. carnosus (pFNBA4), S. carnosus (pFNBB4), and S. carnosus TM300 to nonactivated platelets in PRP was low and within the same range (∼2.5%-3.5% bacteria-positive platelets) (figure 2A). After platelet activation with different concentrations of a-thrombin, adherence of strains S. aureus Cowan 1 (16% bacteria-positive platelets, 1 U/mL thrombin; ), S. carnosus (pFNBA4) (8.5% P ! .001 bacteria-positive platelets, 1 U/mL thrombin; ), and S. P p .003 carnosus (pFNBB4) (9.5% bacteria-positive platelets, 1 U/mL thrombin;
) was significantly increased. In contrast, ad-P ! .001 herence of S. carnosus TM300 was not altered. Adherence of strains S. aureus Cowan 1, S. carnosus (pFNBA4), and S. carnosus (pFNBB4) was not increased or was only slightly increased by the addition of 50 mg/mL Fn (figure 2B).
To clarify the role that plasma proteins play in that interaction, we performed the flow-cytometric adherence assay us- ing GFPs that are devoid of plasma proteins. Adherence of stationary-phase S. aureus Cowan 1, S. carnosus (pFNBA4), S. carnosus (pFNBB4), and S. carnosus TM300 to nonactivated GFPs was in a similarly low range (∼4%-5.5% bacteria-positive platelets). Addition of either Fn (up to 100 mg/mL; figure 3A) or Fg (up to 100 mg/mL; figure 3B ) did not promote that adherence. After activation of GFPs with a-thrombin (1 U/mL), adherence of strains S. aureus Cowan 1, S. carnosus (pFNBA4), and S. carnosus (pFNBB4) to platelets was slightly increased (6%-7% bacteria-positive platelets), whereas adherence of S. carnosus TM300 to activated platelets did not increase ( figure 3C and   3D ). Addition of Fn (up to 100 mg/mL; figure 3C ) significantly promoted the formation of bacteria-platelet associates: 17% bacteria-positive platelets with S. aureus Cowan 1 ( ), P ! .001 12% bacteria-positive platelets with S. carnosus (pFNBA4) (P ! .001), and 13% bacteria-positive platelets with S. carnosus (pFNBB4) (P ! .001). The addition of Fg (up to 100 mg/mL; figure 3D ) promoted the formation of bacteria-platelet associates: 35% bacteria-positive platelets with S. aureus Cowan 1 ( ), 16% bacteria-positive platelets with S. carnosus P ! .001 (pFNBA4) ( ), and 12% bacteria-positive platelets with P ! .001 S. carnosus (pFNBB4) ( ). In contrast, the addition of P p .014 either Fn or Fg did not promote adherence of S. carnosus TM300 to activated platelets. Similar results were obtained when adherence of exponential phase bacteria to activated GFPs was assayed (data not shown).
Capacity of S. aureus FnBPA and FnBPB to Induce Aggregation of Platelets
S. aureus has been recognized as a bacterium that is able to induce aggregation of platelets [30] . Aggregation of platelets is thought to be an important factor in the development of IE, leading to the formation of platelet-bacteria thrombi and thus to an enlargement of the infected vegetation on the heart valves. To clarify whether FnBPs are involved in that function, staphylococcal strains (S. aureus Cowan 1, S. carnosus [pFNBA4], S. carnosus [pFNBA4], and S. carnosus TM300) were tested for their ability to induce aggregation of platelets. With GFPs, none of the strains grown to stationary phase was able to induce aggregation of platelets (data not shown). When PRP was used in the experiment, S. aureus Cowan 1 and S. carnosus (pFNBA4) induced aggregation of platelets with a lag time of min 3 ‫ע‬ 1 ( ) in a monophasic manner (figure 4). In contrast, S. n p 4 carnosus (pFNBB4) and S. carnosus TM300 did not induce aggregation of platelets. Similar results were obtained with exponential-phase bacteria (data not shown).
DISCUSSION
In the present study, we have described the successful construction of a S. aureus-derived phage-display library by use of the improved vector pG8SAET. After panning against immobilized GFPs, we repeatedly isolated clones that contained overlapping DNA fragments (Pf and Pg) encoding the Fn-binding domain of S. aureus FnBPs. In our previous investigation, we could not identify the FnBPs as platelet-binding adhesins, thus confirming the suitability of the pG8SAET vector for use in a phage-display library when complex ligands, such as eukaryotic cells, are used in the panning experiments [14, 15] . S. aureus produces 2 closely related FnBPs, FnBPA and FnBPB. FnBPs have been implicated in the pathogenesis of S. aureus infection by facilitating attachment of the bacteria to host cells and to Fn-coated polymer material and by acting as invasins to cultured host cells [31] [32] [33] . However, to our knowledge, a role for the FnBPs in the S. aureusplatelet interaction has not been suggested before.
To dissect the role that the FnBPs play in the S. aureusplatelet interaction, we used a flow-cytometric adherence assay and S. carnosus strains that heterologously express the S. aureus genes fnbA and fnbB from strain 8325-4 encoding FnBPA and FnBPB, respectively. We found that S. carnosus (pFNBA4) and S. carnosus (pFNBB4) showed increased adherence to activated platelets, compared with the S. carnosus wt strain. Previous results suggested that FnBPs do not play a role in the induction of endocarditis by S. aureus [34] . However, the results of the present study strongly suggest that FnBPs play a role in the induction and/or propagation of IE caused by S. aureus and thus support the recent findings of Que et al. [12] , who reported that Lactococcus lactis cells expressing the fnbA gene have a 100-fold higher infectivity than do L. lactis cells harboring an empty vector, in an experimental rat endocarditis model, and thus correspond to the infectivity of S. aureus [12] .
Because we isolated hybrid phages expressing the Fn-binding domain of FnBPs, we analyzed the capacity of Fn to act as a bridging molecule and to enhance the FnBP-mediated platelet binding. We found that the addition of Fn to activated platelets greatly enhanced binding of S. carnosus (pFNBA4) and S. carnosus (pFNBB4) to platelets, strongly suggesting that Fn indeed acts as a bridging molecule. S. aureus FnBPs are also known to contain an Fg-binding site in their A domain [35] . Therefore, we analyzed the ability of Fg to promote FnBP-mediated adherence to platelets. Our results demonstrate that Fg also is able to promote the adherence of S. carnosus producing either FnBPA or FnBPB to platelets, probably by acting as a bridging molecule. Of interest, promotion of adherence to activated GFPs mediated by Fn is very similar with S. carnosus (pFNBA4) and S. carnosus (pFNBB4), whereas promotion of adherence to activated GFPs mediated by Fg is more pronounced with S. carnosus (pFNBA4) than with S. carnosus (pFNBB4). This difference seems to be statistically significant, at least when 50 mg/ mL Fg was added ( ) ( figure 3D ). The Fg-binding activity P p .01 in FnBPA was located in the 500-aa A domain [35] . In that region, FnBPA and FnBPB exhibit only ∼27% identical and 48% similar amino acids. Thus, the difference in promotion of adherence by Fg observed with FnBPA and FnBPB might be due to sequence differences, which are pronounced in the Fg-binding A domains, whereas the Fn-binding D domains are almost identical with both proteins ( figure 1) .
Furthermore, we analyzed the capacity of the FnBPs to induce aggregation of platelets and found that FnBPA, but not FnBPB, was able to induce aggregation of platelets when present on S. carnosus cells. FnBPA was able to induce aggregation of platelets in PRP, but not in GFPs, indicating that plasma proteins are essential in that interaction. This shows that FnBPA can activate aggregation of platelets independently of other S. aureus surface molecules. In contrast, FnBPB is not able to mediate aggregation platelets either in GFPs or in PRP. Thus, the inability of FnBPB to induce aggregation of platelets correlates with a less-pronounced ability of Fg to promote FnBPB-mediated platelet adherence (see above). Again, sequence differences in the A domain of FnBPA and FnBPB may account for their different abilities to stimulate aggregation of platelets. As a result, we hypothesize that a portion of the A domain of FnBPA, but not that of FnBPB, binds to an unidentified platelet receptor, which further induces aggregation of platelets. Figure 5 summarizes the proposed events involved in the FnBPA-or FnBPB-mediated interaction of S. aureus with platelets. Another possible explanation might be that further S. aureus factors are required for potential FnBPB-mediated aggregation of platelets. However, the difference in aggregation of platelets caused by FnBPA and FnBPB does not seem to be due to different expression levels of the respective genes, as suggested by the results of a Western ligand assay [17] . Furthermore, S. carnosus (pFNBA4) and S. carnosus (pFNBB4) both exhibit invasion of 293 cells to a similar extent [17] .
That the addition of either Fn or Fg in the flow-cytometric adherence assay greatly enhanced the adherence of S. carnosus (pFNBA4) and S. carnosus (pFNBB4) to platelets and that S. carnosus (pFNBA4) induce aggregation of platelets only in PRP, but not in GFPs, suggests that the plasma proteins function as bridging molecules between S. aureus FnBPs on one side and a platelet receptor on the other side (figure 5). Platelet receptors that are potentially involved in that interaction are the Fg receptor GPIIb/IIIa, which also binds Fn and represents the most abundant receptor on platelets (60,000-100,000 copies/platelet), and the Fn receptor integrin a 5 b 1 . During activation of platelets, Fg and Fn are secreted from a-granules and then are bound by the GPIIb/IIIa platelet receptor. Previously, it was suggested that S. aureus-mediated aggregation of rabbit platelets is dependent on Fg but independent of GPIIb/IIIa, because it was not inhibited by the RGDS (Arg-Gly-Asp-Ser) peptide, which is an antagonist of GPIIb/IIIa [36] . However, recently, ClfA, ClfB, and the serine-aspartate repeat protein SdrE were found to be able to aggregate human platelets when the respective genes were expressed in the nonaggregating host strain L. lactis, in a GPIIb/IIIa-dependent manner [22] . Thus, aggregation of platelets induced by S. aureus is a highly multifactorial process, and the results of the present study identify FnBPA, but not FnBPB, as a factor involved. Further analyses are warranted to characterize in more detail the processes that are involved in the different behavior of FnBPA and FnBPB in the S. aureus-platelet interaction. Overall, these findings will help investigators to gain a better understanding of the mechanisms that are involved in the S. aureus-platelet interaction, which is necessary to develop new strategies to combat invasive S. aureus disease, such as IE.
